Golo Lawsuit: GOLO Faces Class Action Lawsuit Over Alleged False Advertising.
What does the GOLO Lawsuit allege?
“The lawsuit claims that GOLO consistently mislabels its product and uses deceptive advertising, which breaks the law and harms the public. If not stopped, it could cause big problems for society.”
GOLO, a Delaware-based company, is facing a class action lawsuit filed by former customer Vincenzza Bubak in the U.S. District Court for the Eastern District of California.
Bubak alleges that GOLO marketed and sold its dietary supplements with false and misleading claims.
In December 2020, Bubak purchased GOLO supplements after being convinced by claims that they would aid in weight loss and provide various health benefits. However, when the supplements did not deliver the promised results, Bubak sought a refund.
She was disappointed to find that she had to pay for the shipping and handling costs to return the product, according to Top Class Actions.
The lawsuit accuses GOLO of engaging in a pattern of “unlawful and unfair business practices” through their deceptive labeling and advertising.
Bubak argues that these practices harm the public and, if left unchecked, could lead to significant societal harm.
This case highlights ongoing concerns about the marketing practices of dietary supplement companies and their impact on consumers.
Read More
✅ Is Smoothstack a “Revature-esque” scam?
Golo Lawsuit Overview (New Update)
The GOLO Lawsuit: Core Issues and Allegations
Core Allegations
The lawsuit against GOLO focuses on claims related to its Release dietary supplement. The core issue is GOLO’s statements about the supplement’s ability to address insulin resistance and aid in weight loss.
Vicenzza Bubak (Plaintiff’s Experience)
Vincenzza Bubak, the lead plaintiff, bought GOLO dietary supplements in December 2020. She claims that the pills did not work as advertised. Additionally, when she requested a refund, she had to pay for the shipping and handling costs.
This case highlights concerns about the truthfulness of health benefit claims made by dietary supplement companies and seeks to hold GOLO accountable for its advertising practices.
Allegations in the GOLO Lawsuit
The lawsuit against GOLO alleges that the company engaged in false and deceptive advertising practices that misled consumers about the benefits of its Release dietary supplement.
According to the lawsuit, these practices amount to unlawful and unfair business practices that could harm the public if left unchecked.
Read More
✅ Nectar Mattress Lawsuit About “Made-In-USA” – Everyone Should Know
✅ Lifewave Lawsuit In-depth A to Z Case Details
✅ C.W. Park USC Lawsuit – Unravelling The Truth Behind In
Key Allegations of the GOLO Lawsuit
1. Improper Implied Disease Claims:
The lawsuit claims that GOLO made statements about Insulin Resistance and their product that imply it can treat diseases, which is improper given the product’s branding.
2. Inadequate Directions for Use:
The lawsuit alleges that GOLO provided insufficient instructions on how to use the supplement effectively.
3. Inappropriate Use of “Clinically-Proven” Language:
The plaintiffs argue that GOLO’s claims of their supplements being “clinically-proven” are misleading. They assert that these claims were not based on peer-reviewed studies and lacked overwhelming evidence and consensus within the scientific community.
The plaintiffs contend that for a claim to be considered scientifically and clinically proven, it must be widely accepted and supported by significant evidence in the relevant field, which they allege GOLO’s claims were not.
What are the law issues at Golo Lawsuit?
- California’s Unfair Competition Law (Cal. Bus. & Prof. Code § 17200)
- California’s False Advertising Law (Cal. Bus. & Prof. Code § 17500)
- California’s Consumer Legal Remedies Act (Cal. Civ. Code § 1750)
These are the Law issues at Golo Lawsuit.
FDA Status of GOLO’s Release Capsule
The Release capsule from GOLO is not approved by the U.S. Food and Drug Administration (FDA), as the FDA is not authorized to approve dietary supplements for safety and effectiveness.
According to the FAQ section on GOLO’s website,
All the ingredients in the capsule are on the FDA-approved list known as Generally Recognized as Safe (GRAS).
The Release capsule contains three minerals:
- Magnesium (Mg)
- Zinc (Zn), and
- Chromium (Cr)
Read More:
✅ Justin O’Brien Vs Smoothstack Lawsuit – Big News
✅ Vegamour Lawsuit Update 2024: Separating Reality from Myth
✅ Trulife Distribution Lawsuit 2024 (Updates): Filter Facts from Fiction
What Says In Golo Website Disclaimer?
GOLO’s website disclaimer states that its product is not meant to diagnose, treat, cure, or prevent any diseases.
Golo also mentioned that the product has not been evaluated by the FDA.
On the FAQs page,
GOLO addresses the question of whether the Release is FDA-approved.
They clarify that FDA approval is not required for supplements and vitamins, but the ingredients must be on the FDA’s Generally Regarded as Safe (GRAS) list.
GOLO also confirms that all ingredients in Release are GRAS-approved.
Additionally, they highlight that there have been over 100 studies conducted on the safety and effectiveness of Release’s ingredients.
Wrap Up – What is the New Update od this GOLO Lawsuit?
GOLO lawsuit reveals that Judge Drozd has ruled in favor of GOLO. In January 2024, the judge granted GOLO’s Motion to Dismiss the lawsuit.
This dismissal comes early in the legal process for a class action lawsuit and represents a significant victory for GOLO.
4 resources
- Truth in Advertising. Case 1:21-cv-00492-DAD-EPG.
- National Library of Medicine. The Association between Adult Weight Gain and Insulin Resistance at Middle Age: Mediation by Visceral Fat and Liver Fat.
- GOLO. FAQs.
Recent Posts
- Smoothstack Coding Challenge: A Comprehensive Review In 2024
- Is Smoothstack Is A Real Company?
- Smoothstack Reviews – Comprehensive Guide In 2024
- FintechZoom PFE Stock – How Pfizer’s Positioning In The Market? - July 10, 2024
- FintechZoom Ford Stock With Performance and Future Projections - July 8, 2024
- Step-by-Step Guide: Integrating QWEFV into Your Business Systems - July 7, 2024